|Day Low/High||22.25 / 22.43|
|52 Wk Low/High||19.52 / 27.00|
Amazon Prime topping 100 subscriptions is just one story to keep your eye on Thursday. What are you watching?
U.S. stock futures point lower; surging oil prices boost equities in Europe and Asia; Amazon says its Prime subscription program has more than 100 million members; P&G to buy German Merck's consumer healthcare unit for $4.2 billion.
Procter & Gamble will pay around $4.2 billion for the consumer healthcare unit of Merck KGaA in the first major deal for the group since activist investor Nelson Peltz joined the board last month.
Germany's Merck KGaA is looking to sell its $1 billion consumer healthcare unit after a group-wide strategic review.
Miners were hit after White House flashes teeth at North Korea
Benchmarks saw a resoundingly positive session Wednesday.
Data helped to boost sentiment toward the global economy among investors and lifted metals prices across the board, with a subsequent read-across into stock markets throughout much of the session.
Investors focused on the potential for higher interest rates.
If the EU finds any problems with the deals, the companies could have to pay up to 1% of global revenue as a fine.
Merck KGaA posted slightly stronger-than-expected first quarter earnings Thursday and nudged its full-year profit guidance higher after a key drug approval in the United States.
Roche, the Swiss drugmaker, was let down by Tecentriq in clinical trials providing scope for Astra to close the gap and a possible boost for Bristol on Wednesday
Fresenius announced a deal to buy U.S. generic drugmaker Akorn Inc for $4.75 billion, or $34 per share.
M&A, French election relief and renewed talk of reforms to taxes and trade all helped to push European stocks higher Tuesday
European stocks extended gains Tuesday as global markets continued to rally in the wake of Emmanuel Macron's victory in Sunday's presidential elections in France and improving corporate earnings.
Fresenius announced a deal to buy U.S. generic drugmaker Akorn Inc for $4.75 billion and the biosimilars unit of German peer Merck KGaA.
London benchmarks rise on commodity exposure while Paris and Frankfurt pare losses.
European Stocks Pushed Lower as 'Trump Trade' Fizzles
Merck KGaA shares tested one-year highs Friday after the Food & Drug Administration approved rare form of skin cancer treatment that could cost patients as much as $13,000 per month.
European stocks whipsawed as investors reacted to a White House resignation, poor eurozone data and Yellen putting tightening on the table with lawmakers
A resignation from the Trump cabinet and worse-than-expected German growth left a sour taste in the mouths of investors
Markets in London and Paris were lower on Thursday, while German stocks bucked the trend as investors responded to corporate earnings and political news.
A bold restructuring from UniCredit in Italy lit a fire under the banking sector.
Shares in the drugmaker climbed after third-quarter earnings and sales beat expectations.
DAX leads European markets higher, but London stocks lag on poor earnings reports.
Jimmy Choo shares surge as first-half revenue jumps, Entertainment One plunges.
European stocks fall on Tuesday amid a string of disappointing results from companies including German power utility RWE.
San Rafael, Calif.-based BioMarin says the deal will lift revenue from the PKU metabolic disorder treatment by up to $80 million in 2016.
Exporters led European stocks lower on Tuesday after China's surprise currency devaluation, as an unexpected fall in German investor confidence stoked concerns about the pace of recovery in Europe.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.